The Tennis Anti-Doping Programme (the ‘Programme’) is managed and enforced by the ITF on behalf of the ATP, WTA and Grand Slams. The Programme applies to all players competing at the Grand Slam tournaments, Davis Cup, Billie Jean King Cup, Hopman Cup, the Olympic Tennis event, the Paralympic Tennis event, other IOC-recognised International Events, WTA tournaments and WTA Finals and WTA Elite Trophy, ATP Tour tournaments and ATP Finals, Next Gen ATP Finals, ATP Challenger Tour tournaments, ITF World Tennis Tour events, ITF Juniors events, ITF Seniors events, ITF Wheelchair events, and ITF Beach Tennis Tour events.
The purposes of the Tennis Anti-Doping Programme are as follows:
-Maintain the integrity of tennis
-Protect the health and rights of all tennis players
The Tennis Anti-Doping Programme maintains a common set of rules and procedures that apply across all levels of tennis. Players are tested for banned substances in accordance with the prevailing version of the World Anti-Doping Agency’s Prohibited List. The Tennis Anti-Doping Programme is fully compliant with the World Anti-Doping Code.
The Programme began in 1993, with three governing bodies - the ITF, ATP and WTA Tour - managing testing at their own events, through the ITF at the independent Grand Slam tournaments, and dealing with any cases arising from their events. Out-of-competition testing was also conducted under the Tennis Anti-Doping Programme.
Since 2006, the ITF has managed, administered and enforced the Tennis Anti-Doping Programme on behalf of the ATP, and on behalf of the WTA since 2007.
An out-of-competition testing programme has been conducted under the Tennis Anti-Doping Programme since 2005. This programme has been fully WADA Code-compliant since out-of-competition testing became mandatory in 2009. Players subject to this programme provide daily whereabouts information in order to permit effective no-notice out-of-competition testing.
For further information on the Tennis Anti-Doping Programme, send an email to email@example.com.
If your enquiry is in relation to product information or to check whether a TUE is required, complete the Product Information Request form on the Tennis Anti-Doping app, free to download onto Android (Google play) and Apple (App Store) devices. Requests for information on pharmaceutical products are processed 7 days a week during office hours, and are normally returned within 24 hours, unless the request is for a large number of products and/or ingredients, in which case processing may take up to 72 hours or more in exceptional circumstances.